THE IBN SINA PHARMACEUTICAL INDUSTRY PLC

The IBN SINA Pharmaceutical Industry PLC

IBNSINA

BD0464IBNSN2

Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 23:00:00 22/05/2024 BST			5-day change	1st Jan Change
236.3 ^BDT	-2.32%		-4.49%	-17.55%

02-01	The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the First Quarter Ended September 30, 2023	CI

The Ibn Sina Pharmaceutical Industry Limited Appoints Shah Abdul Hannan as Chairman of the Board of Directors

September 04, 2012 at 02:24 pm

The Ibn Sina Pharmaceutical Industry Limited has appointed Mr. Shah Abdul Hannan as Chairman of the Board of Directors. The effective date is September 04, 2012.

Latest news about The IBN SINA Pharmaceutical Industry PLC

The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-01	CI
The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the First Quarter Ended September 30, 2023	11-15	CI
The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the Full Year Ended June 30, 2023	30/09/23	CI
The IBN SINA Pharmaceutical Industry Ltd. Recommends Cash Dividend for the Year Ended June 30, 2023	29/08/23	CI
The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	15/05/23	CI
The IBN SINA Pharmaceutical Industry Ltd. has Changed its Name to The IBN SINA Pharmaceutical Industry PLC	26/02/23	CI
The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	31/01/23	CI
The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the First Quarter Ended September 30, 2022	16/11/22	CI
The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the Full Year Ended June 30, 2022	04/10/22	CI
The IBN SINA Pharmaceutical Industry Ltd. Recommends Cash Dividend for the Year Ended June 30, 2022	06/09/22	CI
The IBN SINA Pharmaceutical Industry Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	26/04/22	CI
The IBN SINA Pharmaceutical Industry Ltd. to Build Central Store at Gazipur	24/04/22	CI
The IBN SINA Pharmaceutical Industry Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	25/01/22	CI
The IBN SINA Pharmaceutical Industry Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2021	11/11/21	CI
The IBN SINA Pharmaceutical Industry Ltd. Reports Earnings Results for the Full Year Ended June 30, 2021	27/10/21	CI
The IBN SINA Pharmaceutical Industry Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2021	22/09/21	CI
The Ibn Sina Pharmaceutical Industry Ltd. Reports Earnings Results for the Third Quarter Ended March 31, 2021	29/04/21	CI
The Ibn Sina Pharmaceutical Industry Ltd. Reports Earnings Results for the Second Quarter Ended December 31, 2020	26/01/21	CI
The IBN SINA Pharmaceutical Industry Ltd. Announces Decision to Form A Subsidiary Company	03/01/21	CI
The Ibn Sina Pharmaceutical Industry Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2020	23/12/20	CI
The Ibn Sina Pharmaceutical Industry Ltd. Reports Earnings Results for the Full Year Ended June 30, 2020	21/10/20	CI
The IBN SINA Pharmaceutical Industry Ltd. Recommends Dividend for the Year Ended on June 30, 2020	19/09/20	CI
The Ibn Sina Pharmaceutical Industry Ltd. Reports Earnings Results for the Third Quarter Ended March 31, 2020	30/04/20	CI
The Ibn Sina Pharmaceutical Industry Ltd. Reports Earnings Results for the Second Quarter Ended December 31, 2019	26/01/20	CI
The IBN SINA Pharmaceutical Industry Ltd. to Establish Subsidiary Company	23/01/20	CI

Chart The IBN SINA Pharmaceutical Industry PLC

Duration

Period

Chart The IBN SINA Pharmaceutical Industry PLC

More charts

The IBN SINA Pharmaceutical Industry Ltd is a pharmaceutical company in Bangladesh. The Company is engaged in production, trading and other related activities of Active Pharmaceutical Ingredients (API) and other related products. The Company offers its products under pharma and natural. Its products in a range of therapeutic class, such as Antibiotic, Anti-ulcerant, Antiasthmatic, Antihistamine, Cough Medicines, Antidiabetic, Antispasmodic, Antineuropathic, Cardiovascular drugs (CVS drugs), Central Nervous System (CNS drugs), Gastroprokinetic agent, NSAIDs (nonsteroidal anti-inflammatory drugs) and Laxative. In Antibiotics the Company is enriched in Penicillins with brands Sinamox, Sinaclox, Sinaflox, among others. In Anti-ulcerant portfolio having pioneer brands like Dexlan and Gavisol. Antiasthmatic drugs including Ventisal, Ventisal-L, Xofyl, Montex, among others. Antihistamine brands including Bilamin, Fexomin, Rupamin, Ebamin, Sinamin, Nosemin, Silora, among others.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Ratings for The IBN SINA Pharmaceutical Industry PLC

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

236.3 BDT

Average target price

390 BDT

Spread / Average Target

+65.04%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
THE IBN SINA PHARMACEUTICAL INDUSTRY PLC	-17.55%	62.84M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+18.04%	42.95B
OTSUKA HOLDINGS CO., LTD.	+16.92%	21.38B
SANDOZ GROUP AG	+18.33%	15.05B
CIPLA LIMITED	+19.27%	14.45B
ZYDUS LIFESCIENCES LIMITED	+56.12%	13.04B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-10.73%	6.72B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+11.21%	5.47B

Generic Pharmaceuticals

The IBN SINA Pharmaceutical Industry PLC

Equities

IBNSINA

BD0464IBNSN2

Pharmaceuticals

The Ibn Sina Pharmaceutical Industry Limited Appoints Shah Abdul Hannan as Chairman of the Board of Directors

Latest news about The IBN SINA Pharmaceutical Industry PLC

Chart The IBN SINA Pharmaceutical Industry PLC

Company Profile

Income Statement Evolution

Ratings for The IBN SINA Pharmaceutical Industry PLC

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Generic Pharmaceuticals